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The potential existence of a specific uremia-associated
myocardial depressant factor was explored by evaluating
nine pediatric subjects (3 to 21 years) without evidence
of coronary artery disease or long-standing hypertension
1) before entering a dialysis program, 2) while undergo-
ing a long-term dialysis regimen, and 3) after successful
renal transplantation. Myocardial contractility was
quantitated with load-independent indexes using the end-
systolic pressure-dimension relation (Emax) and the
relation of rate-corrected velocity of shortening to end-
systolic wall stress. Myocardial loading status was de-
termined by the direct measurement of afterload (end-
systolic wall stress) and the functional quantitation of
preload (differences between the relation of fractional
shortening and velocity ofshortening to end-systolic stress).
Most patients (55%) were found to have abnormal
ejection phase indexes of ventricular function either be-
Cardiovascular abnormalities, including congestive heart
failure, occur frequently in patients with renal failure, Ab-
normal left ventricular systolic function has been observed
in some patients (1-7), leading to speculation that uremia
causes myocardial dysfunction, either directly through cir-
culating toxins (8-11) or secondarily through associated
metabolic abnormalities such as hypocalcemia or hyper-
magnesemia (12,13). Improved ventricular function after
dialysis or transplantation has also been interpreted as evi-
dence for a specific uremia-associated cardiomyopathy
(14-22). However, the implications of these findings con-
cerning myocardial contractility are obscured by the fact
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fore or after entry into dialysis. However, contractility
was normal in all subjects at each of their evaluations,
and no change in contractility was found after dialysis
or transplantation. Loading status was highly variable
and usually abnormal before transplantation and ac-
counted entirely for the abnormalities of fractional
shortening and velocity of shortening. Transplantation
invariably resulted in normalization of loading status
and ejection phase indexes of ventricular function.
In these children and young adults with uremia, ab-
normal ejection phase indexes of ventricular function
were frequent and caused by associated abnormalities
in ventricular loading. Contractility, however, was nor-
mal and no evidence of a uremia-associated myocardial
depressant was found.
(J Am Coil Cardiol /987;10:1085-94)
that ventricular function has invariably been evaluated using
ejection phase indexes of left ventricular performance such
as ejection fraction or systolic time intervals. These indexes
are known to be highly sensitive to left ventricular loading
conditions (23-27), which are usually abnormal in uremic
patients and change radically with dialysis or renal trans-
plantation. Therefore, uncertainty remains as to whether the
observed abnormalities are secondary to depressed contrac-
tility or altered loading conditions.
The recent development and validation of load-indepen-
dent indexes of left ventricular contractility enable recon-
sideration of this issue. In particular, building on a series
of observations in the isolated heart, the end-systolic pres-
sure-volume or pressure-diameter relation (Emax) has been
shown to be both sensitive to contractile state and indepen-
dent of loading conditions within the physiologic range
(26,28,29). The clinical usefulness of this index has been
demonstrated, and noninvasive methods for its determina-
tion have been developed (30). In addition, we have recently
described a method of force-velocity analysis whereby al-
0735-1097/87/$3.50
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terations in afterload, preload and contractility can be dis-
tinguished (27). These methods were applied to a group of
children and young adults with end stage renal disease to
determine the range of left ventricular mechanics and con-
tractile state found in these patients and the effect of dialysis
or renal transplantation, or both. Because we specifically
wished to evaluate the effects of the uremic state, a young
and otherwise healthy group of subjects was selected to
avoid the potential confounding effects of coronary artery
disease or long-standing hypertension, as would be found
in older subjects. Finally, because acute alterations in elec-
trolyte status or fluid balance may directly alter contractile
state or elicit autonomic reflexes that secondarily affect ino-
tropic state, all evaluations were performed at least 24 hours
after interventions such as dialysis or transfusions.
Methods
Studysubjects (Table 1). The study group consisted of
nine patiertts aged 3 to 21 years (mean 9.9) with end stage
renal disease. The duration of chronic renal failure (defined
as a serum creatinine concentration>3 mg/dl) was from I
to 4 years. Two subjects had hypertension that was con-
trolled with medical therapy (Patient 8 received captopril,
and Patient 2 was treated with clonidine and hydralazine).
All subjects were free of any evidence of structural heart
disease on the basis of physical examination and evaluation
with two-dimensional and Doppler echocardiography. Six
subjects were first evaluated before entering the dialysis
program, with repeat evaluation 2 to 6 months after stabi-
lization on long-term dialysis. Three of these patients sub-
sequently underwent successful renal allograft transplanta-
tion and were studied again I to 3 months later. Three
additional patients were first studied after entering long-term
dialysis and were reevaluated 2 to 4 months after successful
renal transplantation. Altogether, therefore, data were avail-
able for six patients before and after dialysis and for six
patients before and after transplantation. Afterload aug-
mentation was not performed in one subject presenting with
congestive heart failure, so that Emax data are available
before and after dialysis in five subjects and before and after
transplantation in five subjects.
Postdialysis evaluation. All patients were evaluated 24
to 48 hours after a dialysis session, except for Patient 9,
who was treated with long-term peritoneal dialysis. The
dialysate used was the same for all subjects, consisting of
3.5 mEq/liter of calcium, 2.0 mEq/liter of potassium and
36 mEq/liter of acetate with no bicarbonate. Serum calcium
was normal in all subjects before dialysis (Table I). Weight
loss during dialysis varied from I to 9% of body weight.
Datarecordings. Data were collected using previously
reported methods (27). Echocardiograms were obtained us-
ing a Hewlett-Packard n020A two-dimensional ultrasound
system with two-dimensional-directed M-mode capabili-
ties. High speed (100 mm/s) hard copy M-mode echocar-
diograms were obtained of the left ventricular minor axis
with simultaneous phonocardiogram, electrocardiogram and
indirect carotid pulse tracing. The phonocardiogram was
recorded at the right upper sternal border, and simultaneous
M-mode recording of aortic valve closure was made to per-
mit positive identification of the aortic component of the
second heart sound. A Dinamap 845 vital signs monitor
(Critikon, Inc.) was used to obtain peak systolic and dia-
stolic blood pressure measurements. Long- and short-axis
two-dimensional echocardiographic views of the left ven-
tricle were obtained for evaluation of regional wall motion.
After baseline recordings, 0.01 mg/kg body weight of
intravenous atropine was given to prevent reflex bradycar-
dia. A continuous 15 tLg/kg per min intravenous infusion
of the pure alpha-adrenergic agonist methoxamine was then
initiated, and repeat data recordings were obtained every I
to 2 minutes during a gradual increase in peak systolic
pressure to 30 to 60 mm Hg over baseline. The infusion
was then discontinued, and repeat recordings were obtained
until baseline conditions were restored. Total infusion time
Table 1. Patient Profile, Serum Electrolytes and Body Mass Change During Dialysis
Patient Age CRF Ca K
Body Mass (kg)
No. (yr) (yr) Medications (mEq/liter) (mEq/liter) Pre Post
I 5 2 9.9 5.2 12.7 12.4
2 21 I Clonidine, hydralazine 9.5 5.0 61.6 59.9
3 19 4 Phenytoin, furosemide 8.4 4.7 48.8 47.2
4 7 I 10.6 5.3 14.6 14.1
5 13 3 9.0 5.8 26.0 24.0
6 9 2 Captopril 10.4 4.0 32.3 29.2
7 15 2 NA NA NA NA
8 17 14 Phenobarbital NA 5.2 48.9 48.2
9 3 2 8.9* 5.5* 13.5*
*Data obtained while the patient was undergoing long-term peritoneal dialysis. CA = serum calcium; CRF = duration of chronic renal failure; K
= serum potassium; NA = not available; Post = after dialysis; Pre = before dialysis.
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ranged from 7 to 16 minutes, and time to restoration of
baseline conditions was 15 to 28 minutes.
Data analysis. High quality tracings from each subject
were selected for computer analysis on a Franklin Quantic
1200echocardiographic review station (Bruce Franklin, Inc.).
This device has a digitizing pad with a sampling rate of 80
points/em, giving a net digitizing rate of 800 points/so In
addition to baseline recordings, tracings for each subject
were selected after atropine and during methoxamine in-
fusion over a range of blood pressure values for calculation
of Emax. Recordings with heart rate variation of more than
10 beats/min from the postatropine values were not used
for Emax calculation,
The carotid pulse tracing as well as the left ventricular
echocardiogram including the endocardial septal surface
and the endocardial and epicardial borders of the left ven-
tricular posterior wall were digitized, The carotid pulse trac-
ing was corrected for time delay by electronically aligning
the dicrotic notch with the aortic valve component of the
second heart sound, From the digitized data, the following
instantaneous measurements were derived by averaging three
to five cardiac cycles: 1) left ventricular pressure throughout
ejection, determined by linear interpolation of the instan-
taneous points of the carotid pulse tracing as previously
described (27)-this method has been validated against an
intraarterial standard in our laboratory (31); 2) left ventric-
ular internaldiameter; 3) left ventricularposterior wall thick-
ness; and 4) left ventricular wall stress calculated according
to the angiographically validated formula (32):
ws = (P)(D)(l.35)
(h)(1 + [hlD])(4)'
where WS = wall stress (g/crrr'). P = pressure (mm Hg),
D = dimension (ern), h = posterior wall thickness (cm)
and 1,35 is the conversion factor from mm Hg to g/cm".
Wall stress, velocity of shortening and fractional short-
ening relations. End-diastolic measurements were taken at
the time of maximal left ventricular dimension, and end-
systolic measurements were taken at the time of aortic valve
closure. Left ventricular ejection time was measured from
the simultaneouscarotid pulse tracing and adjusted to a heart
rate of 60 beats/min by dividing by the square root of the
RR interval. The left ventricular percent fractional short-
ening was calculated as the difference between the dimen-
sions at end-diastole and end-systole divided by end-dia-
stolic dimension, The rate-adjusted mean velocity of
shortening was calculated by dividing fractional shortening
by the rate-adjusted ejection time. End-diastolic dimension
index was calculated by dividing end-diastolic dimension
by the cube root of body surface area. The relation of frac-
tional shortening and rate-adjusted velocity of shortening to
end-systolic wall stress was calculated for each individual
from tracings obtained under baseline conditions, and the
mean values for these indexes were obtained for each of the
four groups. The individual and group values for the relation
of end-systolic wall stress to rate-adjusted velocity of short-
ening and end-systolic wall stress to fractional shortening
were then compared with the previously reported normal
values for these indexes in our laboratory (27).
Calculation ofEmax. The relation of instantaneous pres-
sure to left ventricular internal dimension throughout ejec-
tion at numerous levels of blood pressure during methox-
amine infusion was calculated, and the appropriate value
for each curve was selected for calculation of Emax. As
illustrated in Figure I, aortic valve closure occurs after the
point in systole when the pressure/dimension ratio is max-
imal, This is a result of the period of time after cessation
of anterograde flow into the aorta and before aortic valve
closure (known as the "hang out" interval) during which
pressure continues to decrease but ventricular volume is
static (33). As discussed by Sagawa (28), the time of max-
imalelastance (that is, the maximal pressure:dimensionratio
in isovolumic contractions) occurs earlier in the cardiac
cycle. Therefore, calculation of Emax was performed using
the value at which the pressure/dimension ratio attained its
maximal value, rather than the time of aortic valve closure,
which was used for the end-systolic measurementsdiscussed
previously. For each Emax determination, 6 to 12 points
were used to fit an equation of the form: P = mD + b,
using simple linear regression (least squares method), where
P = pressure, m = slope, 0 = dimension, and b = Y
intercept. The X intercept (that is, the X value when P =
0) was calculated and the slope and X intercept of this line
were normalized to the cube root of body surface area to
determine Emax and X intercept, respectively (30).
Figure l. Examples of systolic pressure-dimension curves (from
the time of onset of aortic ejection to the time of aortic valve
closure) generated atseveral levels ofarterial pressure during meth-
oxamine infusion in one subject. The upper left corner of each
curve (maximal pressure-dimension ratio) is determined. and the
best linear fit (dotted line) is calculated. The slope of this line
and the X axis intercept are adjusted for the cube root of body
surface area to obtain Emax and the X-intercept, respectively.
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Statistical analysis. Data are reported as mean ± I
standard deviation unles s otherwise noted . Comparisons be-
tween pre- and post-dialysis and pre- and posttransplantation
were performed using the t test for paired data, with a
probability (p) value < 0 .05 considered to be statistically
significant.
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Results
Blood chemistry data. Clinical, hemodynamic and
echocardiographic data for each subject are presented in
Tables I and 2. Hematocrit was not significantly higher in
the postdialysis group compared with predialysis status.
However, there was a significant increase in hematocrit after
renal transplantation. Blood area nitrogen was significantly
lower after dialysis compared with predialysis conditions,
and both blood urea nitrogen and creatinine were signifi-
cantly lower after transplantation . All subjects had normal
values for blood urea nitrogen and creatinine at the time of
evaluation after transplantation . Although large changes were
noted in some individuals, blood pressure in the group was
not significantly different after dialysis or transplantation .
Left ventricular dimensions and function (Fig. 2). Di-
mension at end-diastole tended to be lower after dialysis ,
but did not attain statistical significance. End-systolic di-
mension , fractional shortening , and rate-adjusted velocity
of shortening were not significantly different after dialysis ,
although large individual changes were noted . In contrast,
fractional shortening and rate -adjusted circumferential
shortening velocity were significantly higher and end-sys-
tolic wall stress was significantly reduced after transplan-
tation.
Emax (Table 2, Fig. 3). No significant change in Emax
or X intercept occurred between groups after dialysis or
transplantation (Table 2). In addition, in contrast to frac-
tional shortening and rate-adjusted shortening velocity, in
all individuals the difference between sequential studies was
minimal. All Emax values were within the range of normal
for our laboratory (;:0:90 mm Hg/cm per m2/J ) , indicating
normal contractility.
Ejection phase indexes and loading conditions (Fig. 4
and 5). Five of nine subjects were noted to have abnormal
ejection phase indexes of ventricular function (defined as
fractional shortening < 28% or rate-adjusted velocity of
shortening < 0.90) at one or more evaluations. However,
when the effect of afterload was examined by considering
the end-systolic wall stress to rate-adjusted shortening ve-
locity relation, all data points were within the normal range
(27), indicating normal contractility (Fig . 4 , upper panel) .
When the relation of fractional shortening to end-systolic
wall stress was examined, three of nine subjects were noted
to have abnormally low values while receiving long-term
dialysis (Fig. 4, lower panel). The end-systolic wall stress
to fractional shortening relation is influenced by both preload
END-DIASTOLIC DIMENSION INDEX
40%
30%
20%
FRACTIONAL SHORTENING
~ ~1.2 ~1.0 /---~0 .8 /
RATE-CORRECTED VELOCITY
OF SHORTENING
Figure 2. Effect of dialysis and renal transplantation on end-
diastolic dimension index, fractional shortening and rate-adjusted
shortening velocity in each subject. Although large changes oc-
curred in some individuals, only the mean changes in fractional
shortening and rate-adjusted shortening velocity after renal trans-
plantation attained statistical significance .
status and contractility (27). and in the presence of normal
contractility (as indicated by both the Emax and end-systolic
wall stress to rate-adjusted velocity of shortening values) an
abnormally low end-systolic wall stress to fractional short-
ening relation implies a low preload.
The effect of dialysis or renal transplantation, or both,
011 left ventricular loading conditions in two subjects is
illustrated in Figure 5 . In Subject 5, dialysis was associated
with a significantly higher aftcrload (greater end-systolic
wall stress) with no change in contractility (the end-systolic
wall stress to rate-adjusted shortening velocity relation changed
in a fashion parallel to the mean population regression line
b, to b2 in Fig. 5, upper panel. Subject 2 had no change in
afterload or contractility after dialy sis (a , to a2 in Fig. 5 ,
upper panel) . Both subjects, however, demonstrated a sig-
nificant reduction in the end-systolic wall stress to fractional
shortening relation (movement orthogonal to the mean
regression line a, to a2 and b, to b2 in Fig . 5 , lower panel) .
In the presence of unaltered contractile state, this finding
implie s significant preload reduction (27) . After transplan-
tation, subject 5 had a lower afterload (reduced end-systolic
wall stress), no change in contractility (position of the end-
systolic wall stress to rate-adjusted velocity of shortening
relation with respect to the mean regression line [b2 to b,
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Table 2 . Effect o f Dialysis and Renal Trans p lantation o n all Variables in Eac h Subject
00 •
'(' V>
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...
Patient
No . Stat us GSA HCT BUN Cr SBP DBP HR EDD EO DI ESD FS Vcfc ESS Ema x X Int
Predi alysis 0 .51 2 1 112 6 .7 124 68 116 3 .0 3 .8 2. 1 30% 0.85 5 1 97 1. 19
Postdi alysis 0 .56 22 89 5 .2 102 59 140 3 . 1 3 .8 2. 1 32% 0 .89 45 93 1.27
2 Predialysis 1.73 22 140 11.2 165 106 93 5 .9 4. 9 4 .1 31 % 0 .79 98 129 2.17
Postdialysis 1.68 23 105 13 .6 155 99 74 5.4 4 .6 4 .2 22% 0 .78 96 140 2 .22
3 Pred ialysis 1.42 17 9 1 10.2 115 65 47 4 .3 3.8 2.7 37 % 1.25 27 115 1.87
Postdialysis 1.42 23 69 9 .3 106 6 1 67 4.2 3. 7 2.8 33 % 1.30 24 110 1.78
4 Predi alysis 0. 63 12 144 6 .7 126 85 120 3.6 4 .2 2 . 1 42 % 1.30 26 173 1.86
Postdial ysis 0 .59 28 67 8.4 116 84 104 2 .5 3 .0 1.7 32% 1.26 32 174 1.43
Postt ransp lan t 0 .61 37 14 0.4 119 83 93 3 .0 3.5 2.0 33% 1.24 30 164 1.65
5 Predialysis 0 .93 24 88 6 . 1 138 78 137 3. 1 3 .2 1.8 42 % 1.24 20 140 1.15
Postdialysis 0 .9 1 23 80 8.9 188 128 130 3.3 3.4 2 .4 27% 1.05 55 152 130
Posttransplant 0 .99 39 20 0 .8 119 70 100 3.7 3.7 23 38 % I. 15 29 140 1.44
6 Predi alysis 1.07 22 77 5.9 141 101 107 5 .5 4 .3 4 .5 18% 0 .68 104
Postdialysis 1.0 7 19 6 1 5 .8 138 83 120 4 .6 3.4 3 .5 24% 0 .80 85
Pos uranspla nt 1.26 29 20 1.4 110 58 84 4 .3 4.0 3.0 30% 1.0 3 40
7 Pretransplant 0 .97 24 8 1 9 .8 156 87 80 5 .0 5. 1 3.4 32'7<: 0 .88 70 90 1.76
Postt ransplant 0 .97 39 26 0 .8 114 53 57 4 .5 4 .6 3. 1 34 '7<: 1.05 26 97 1.89
8 Pretransplant \ .4\ 28 66 10.0 102 6\ 82 5.3 4 .7 3 .9 28Ck 0 .86 62 103 2.47 Cr
Posttransplant 1.46 40 21 0 .9 117 58 53 5 .5 49 3.6 35% 1. 13 33 96 2.07 ::]
9 Pretransplant 0 .65 19 75 7. 1 104 58 139 3 . 1 3 .6 1.8 39'7<: 1.30 29 127 1.4 1 <rr.
Z
Posttransp lant 0 .67 42 17 0 .2 135 85 105 3 .2 3 .7 2.0 37o/c 1.27 35 11 8 1.35 ;;Q
Mean Predi alysis 1.05 20 109 7.8 135 84 !O3 4 .2 4 .0 2.9 33 1.02 54 1.10 1.6 i'S
±SO ± 0 .47 ± 4 ± 29 =: 2. 3 ± 18 ± 17 ±3 1 ± 1.2 =:0 .6 =: 1.1 ±9 .1 ± 0. 27 =:38 =:28 =:0 .5 S>Mean Postdi alysis 1.04 23 79* 8 .5 124 86 106 3.9 3 .6 2 .8 28 1.0 I 56 131 1.6
'"
± SO ± 0 .42 ±3 ± 26 :t 2 .\ =:20 :t 27 =:30 ± 1.1 =:0 .5 ±0.9 =:4 .6 ± 0 .22 ±29 ± 3 1 ±0.4
(/l
-<
Mean 24 72 8 .3 132 84 103 3 .9 2.8 1.05 56 129 1.7
Vl
Pretransplant 0 .93 4 .0 31 -;0
±SO :t 0 .30 ± 4 = 1> :t 1.6 =:34 =:25 ± 26 =: 1. 1 =:0 .8 ± 0. 9 =:5 .3 ± 0 . 19 =:22 =:34 =:0.5
nMean Posttransplant 0 .99 38 20* 0 .8* 119 68 82* 4 .0 41 2.7 35* I. 15* 29* 123 1 8 3::
=:SD ± 0. 27 = 5 =7 =: 1.5 ±9 ± 14 ~22 =:0 .9 ±0.6 ± O.7 =2 .9 =:0 . 10 ±5 .3 ± 29 =:0.4 rr.IJ
::t:
*p 0 .05 versus status before inter vent ion . BSA = body surface area (01') : BUN = blood urea nitro gen (rng/dl ): Cr = cre atinine (rng/dl); DBI' = diastolic blood :>z
pressure (0101 Hg) ; EOD = end -diastolic dimension (em ); EODI = indexed end-diastolic dime ns ion (cm/m' ' ); Emax = normalized slope of end-systoli c pressure- nIJ
VlO
dimension relatio n (mrn Hg/cm per cm" ); ESO = end -systolic dimension (em): ESS = end,systolic stress (g /c m" ); FS = fracti on al shortening (%); Hct = hem atoc rit _ rz :>('7<: ): HR = heart rate (beats/min); SBP = systolic blood pressure (rnm Hg) : SD = standa rd de viation ; Vcfc = rate-corrected shorte ning veloc ity (circ/s per s ' ' ); X Int c Z
= intercept of the normalized end-sys tolic pressure-dimension relation (cm/crrr' ") . ;::; ~
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Figure 3. Effect of dialysis and transplantation on Emax and X 15 a
intercept. Values in all subjects were essentially unchanged by
either intervention.
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100
in Fig. 5, upper panel] was unchanged), and higher preload
(higher values of the end-systolic wall stress to fractional
shortening relation relative to the mean group regression
line in the presence of unaltered contractility [b2 to b, in
Fig. 5, lower panel]).
Effects of dialysis and renal transplantation (Fig. 6).
When the group data were considered, dialysis was asso-
ciated with no mean change in afterload or contractility
(unaltered end-systolic wall stress and end-systolic wall stress
to rate-adjusted velocity of shortening relation) (Fig. 6, up-
per panel), but a reduction in preload (downward shift of
the end-systolic wall stress to fractional shortening relation
[Fig. 6, lower panel], with no change in contractility).
Transplantation resulted in a significant afterload reduction
(lower end-systolic wall stress) and secondary increase in
rate-adjusted velocity of shortening and fractional short-
ening, with no change in contractility (position of the end-
systolic wall stress to rate-adjusted velocity of circumfer-
ential shortening relation with respect to the group mean
regression line unchanged) (Fig. 6, upper panel) or preload
(concordance of the end-systolic wall stress to rate-adjusted
velocity of shortening and end-systolic wall stress to frac-
tional shortening relation) (Fig. 6). Although the alterations
in afterload, preload and ejection phase indexes of ventric-
ular function in the group data followed these patterns,
marked individual variation was present for each of these
variables. In spite of the large variability in ventricular short-
Figure 4. Individual end-systolic stress to rate-adjusted velocity
of shortening (upper panel) and end-systolic stress to fractional
shortening (lower panel) data points for all nine subjects. The
meannormalregressionlineand 95% confidence intervalsfor these
indexes in our laboratory are shown. Sequential studies in indi-
vidual subjects are connected by arrows. All end-systolic stress
to rate-adjusted shortening velocity values are within the normal
range, indicatingnormalcontractility. In contrast, subnormal end-
systolic stress to fractional shortening values were found in three
subjects after dialysis, indicating reduced preload status. Move-
ment of end-systolic stress to rate-adjusted shortening velocity
values in any individual between sequential studies was parallel
to the regression line, implying unaltered contractile state.
ening and loading conditions seen among individuals, the
response of contractile state was entirely uniform, showing
the same lack of change in each individual with each in-
tervention.
Discussion
Left ventricular contractile state in uremia. In this
group of young subjects with end stage renal disease, no
abnormalities of left ventricular contractile state were found,
nor was there any change in left ventricular contractility
after dialysis or renal transplantation. Similar to the findings
of previous investigators, when ventricular function is eval-
uated using the usual ejection phase indexes of fractional
shortening or velocity of shortening, most uremic patients
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Figure 5. Effect of dialysis or transplantation, or both, on the
end-systolicstressto rate-adjusted shorteningvelocity relation (up-
per panel) and the end-systolic stress to fractional shortening
relation (lower panel) in two representative subjects . Subject 2
had no changein afterload or contractility (unchanged end-systolic
stress to rate-adjusted shortening velocity relation) after dialysis,
but a marked reduction in preload (a, to a2 in lower panel) was
found. After dialysis, Subject 5 had an increase in afterload (higher
end-systolic stress) with no change in contractility (distanceof the
end-systolic stress to rate-adjusted shortening velocity relation from
the mean regression line is unchanged [b, to b2in upper panel]).
There was an associated reduction in preload, as indicated by the
decrease in the end-systolic stress to fractional shortening relation
in spite of an unaltered contractile state. After transplantation (b,
to b.), the reverse was seen, with lower afterload, higher preload
and no change in contractility .
have abnormal values. We were able to demonstrate that in
each case, this was not related to abnormal contractility
even in the presence of clinical congestive heart failure, but
was secondary to reduced preload or excess afterload, or
both. Marked changes in ventricular size and ejection phase
indexes were seen with dialysis and renal transplantation ,
with large interindividual variability. In general, dialysis
was assoc iated with a reduction in preload status and a
resultant decrease in fractional shortening and end-diastolic
dimension, with no change in afterload or contractility. Renal
transplantation resulted in a reduction of afterload, with
increased fractional shortening and velocity of shortening
and no change in preload or contractility. Normalizat ion of
loading conditions was invariably associated with restora-
tion of normal ejection phase indexes.
The patients included in this study were young and with-
Figure 6. Mean values(::': SO)of the relationofend-systolicstress
to rate-adjusted shortening velocity (upper panel) and fractional
shortening (lower panel) in the four patient categories (before and
after dialysis and transplantation). In general, dialysis was asso-
ciated with no change in contractility (end-systolic stress to rate-
adjusted shortening velocity relation is unaltered) and a decrease
in preload (movement of the end-systolicstressto fractional short-
ening relation away from the mean regression line without altered
contractility). Incontrast. renal transplantation was associated with
a reduced afterload (lower end-systolic stress), no change in con-
tractility (end-systolic stress to rate-adjusted shortening velocity
position with respect to the mean regression line is unaltered) and
no change in preload (concordance of the end-systolic stress to
fractional shortening and end-systolic stress to rate-adjusted short-
ening velocity relations).
out other potentially confounding factors such as coronary
artery disease or long-standing hypertension. This selection
bias enables conclusions to be drawn concerning the direct
effects of uremia on myocardial contractility without con-
cern that any observed abnormalities may be secondary to
these other factors. In fact, normal contractility was found
in all phases of therapy. suggesting that any observed ab-
normalities of contractility in subjects with chronic renal
failure are due to additional complications and are not in-
herent to the uremic state . Likewise , data were intent ionally
obtained when patients were in relatively steady state con-
ditions to avoid the potential acute effects of electro lyte
shifts in the immediate postdialysis period . The marked
heterogeneity of the induced changes in afterload and pre-
load that we observed would be anticipated in an ambulatory
group of patients with varying degrees of residual renal
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function, hypertension and fluid and electrolyte intake. In
spite of marked and varying alteration of loading conditions,
however, myocardial contractility remained remarkably
constant.
Is there a uremic cardiomyopathy? The existence of a
specific uremic cardiomyopathy has been controversial
(34,35). Previous investigators have noted abnormal ejec-
tion fraction (l,2), stroke work index (4,18), velocity of
shortening (1,2,5,6,12,13,16,21), systolic time intervals
(5,14,16,19,22) and fractional shortening (6,12,15) in uremic
patients. Interpretation of these findings is problematic since,
as shown in this study, afterload and preload are frequently
abnormal in this group and each of these indexes is highly
dependent on ventricular loading conditions. In general, left
ventricular loading status either has not been assessed or
has been assessed with use of inadequate measures. In par-
ticular, blood pressure has often been used as a measure of
ventricular afterload. However, the extent of myocardial
shortening is determined by the force-resisting fiber short-
ening at end-systole, which is best represented by end-sys-
tolic wall stress (27,36). According to the Laplace relation,
wall stress is determined by pressure, dimension and wall
thickness. In situations associated with large changes in
ventricular wall thickness or dimension, blood pressure is
a particularly unsuitable measure of afterload. In addition,
end-systolic pressure has a variable relation to peak or di-
astolic pressure, further limiting pressure measurements at
these points in the cardiac cycle as measures of afterload.
For example, we found a significant decrease in wall stress
at end-systole after renal transplantation without a signifi-
cant change in systolic or diastolic blood pressure.
A potentially confounding variable in this study is the
higher hematocrit in some patients after dialysis and renal
transplantation. Chronic anemia results in augmentation of
ejection phase indexes of ventricular function (37). Al-
though this effect has been ascribed to the altered loading
conditions that accompany anemia, recent evidence (38)
suggests the presence of a noncatecholamine positive ino-
tropic factor in the serum of patients with chronic anemia.
However, in that study (38), subjects with renal failure were
not included and the effect of this agent on in vivo con-
tractility was not determined. Although it is possible that
in our study, a decrease in contractility due to correction of
anemia was counterbalanced by an equal and opposite effect
of dialysis or transplantation, or both, this appears unlikely
because patients who experienced no change in hematocrit
did not demonstrate an increase in contractility.
Methodologic considerations. The potential limitations
of the methods used for evaluation of left ventricular me-
chanics have been previously discussed in detail (27,30).
The use of ventricular dimension as a measure of left ven-
tricular volume assumes symmetric left ventricular wall mo-
tion and normal chamber configuration, factors confirmed
in these subjects by two-dimensional echocardiography. The
load-independence of Emax within the physiologic range
has been confirmed by a number of investigators (28,30).
The method employed here for calculation of Emax relies
on a large number of data points generated over a wide
range of pressure values, thereby avoiding some of the lim-
itations inherent in calculations based on a more limited
number of observations. This method involves the direct
determination of Emax , eliminating any assumptions con-
cerning the use of systolic blood pressure or the correct
timing of end-systolic blood pressure, and avoiding the use
of minimal or end-systolic dimension to estimate the true
Emax pressure-dimension values. This contrasts with meth-
ods that rely on measurement of the end-systolic pressure-
volume relation at the time of aortic valve closure as an
estimate of Emax (28-30). Finally, the concordance of two
different load-insensitive measures of contractile state (Emax
and the end-systolic wall stress to rate-adjusted velocity of
shortening relation) that are determined from separate data
recordings and rely on independent mechanical properties
of the myocardium strongly supports the reliability of these
findings.
Role ofheart rate. Significant alterations in heart rate at
rest were noted in individual subjects during sequential eval-
uations. Studies on excised strips of myocardium (39), iso-
lated hearts (40) and human subjects (41,42) have indicated
that acute tachycardia enhances the contractile state of myo-
cardium. In particular, higher Emax values have been found
in conscious dogs during atrial pacing-induced tachycardia
(43). For this reason, autonomic reflex bradycardia was
prevented during methoxamine infusion by pretreatment with
atropine, and calculations were performed using data ob-
tained at stable heart rates. In contrast, it was not possible
to avoid differences in heart rate in studies before and after
dialysis and before and after transplantation. The influence
of chronic alterations in heart rate on myocardial contrac-
tility are not known. The absence of changes in Emax in
parallel with the changes in heart rate and the concordance
of Emax values with end-systolic wall stress to rate-adjusted
velocity of shortening values (a rate-adjusted index) suggest
that this effect is not large.
Role of altered afterload and contractility. This study
illustrates the utility of this methodology for distinguishing
among the effects of altered afterload, preload and con-
tractility on ventricular function. Preload in particular has
been difficult to compare among patients. Although diastolic
pressure, volume and wall stress have been commonly used,
end-diastolic fiber length is the true determinant of the Frank-
Starling effect. The relation of each of these alternative
measures to end-diastolic fiber length is dependent on myo-
cardial compliance and zero pressure diastolic volume. By
comparing the end-systolic wall stress to fractional short-
ening and end-systolic wall stress to rate-adjusted velocity
of shortening relations, a functional component is included
in the analysis that directly reflects the net effect of altered
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diastolicpressureand volume on the degree of myofilament
overlap, This permits comparisons between subjects and
between observations separated in time in individual sub-
jects where alterations in chamber compliance or zero pres-
sure volume may have occurred.
Clinical significance. In addition to direct myocardial
depression from a circulating toxin associated with uremia,
chronic renal failure has the potential to cause myocardial
dysfunction through chronic hypertension (44), premature
atherosclerosis due to abnormal carbohydrate and lipid me-
tabolism (45), cardiomyopathy associated with iron over-
load (46,47) and volume overload injury due to chronic
anemia, hypervolemia and iatrogenic arteriovenous fistulas
(48,49). We have purposely studied a group at low risk for
these potentially confounding elements to permitevaluation
of any intrinsic myocardial depressant factor. Although no
evidence of such a factor was found, these patients are
clearlyat high risk for myocardial injurydue to othercauses,
and any abnormalities of contractility observed in these pa-
tients must take these additional adverse influences into
consideration. However, abnormal ejection phase indexes
of ventricular function in a young group of subjects appear
secondary to abnormal loading conditions and respond to
therapy that normalizes loading status, potentially avoiding
the additional hazardsassociated with the use of digitalis in
these subjects.
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